Anzeige
Mehr »
Login
Donnerstag, 03.04.2025 Börsentäglich über 12.000 News von 693 internationalen Medien
Warum Almonty Industries zum Schlüsselplayer für NATO-Staaten wird
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A14X6S | ISIN: US15870P3073 | Ticker-Symbol: 2I3
Frankfurt
03.04.25
08:59 Uhr
7,750 Euro
+0,100
+1,31 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
CHAMPIONS ONCOLOGY INC Chart 1 Jahr
5-Tage-Chart
CHAMPIONS ONCOLOGY INC 5-Tage-Chart
RealtimeGeldBriefZeit
7,6507,85014:32
7,6507,90014:32

Aktuelle News zur CHAMPIONS ONCOLOGY Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
17.03.CHAMPIONS ONCOLOGY, INC. - 10-Q, Quarterly Report1
12.03.Champions Oncology target raised to $12 at Craig-Hallum1
11.03.Champions Oncology Non-GAAP EPS of $0.36 beats by $0.37, revenue of $17M beats by $4.07M2
11.03.CHAMPIONS ONCOLOGY, INC. - 8-K, Current Report2
CHAMPIONS ONCOLOGY Aktie jetzt für 0€ handeln
11.03.Champions Oncology, Inc.: Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million229HACKENSACK, NJ / ACCESS Newswire / March 11, 2025 / Champions Oncology, Inc. (Nasdaq:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, today...
► Artikel lesen
06.03.Champions Oncology, Inc.: Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025251HACKENSACK, NJ / ACCESS Newswire / March 6, 2025 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will...
► Artikel lesen
18.02.Champions Oncology, Inc.: Champions Oncology Announces 17 Abstracts Accepted for Presentation at the 2025 American Association for Cancer Research Annual Meeting78HACKENSACK, NJ / ACCESS Newswire / February 18, 2025 / Champions Oncology Inc. (NASDAQ:CSBR), a global leader in preclinical oncology research and clinical specialty testing, today announced the acceptance...
► Artikel lesen
08.01.Champions Oncology erweitert sein klinisch-bioanalytisches Leistungsportfolio mit neuer Technologie und zusätzlichem Führungsexperten305HACKENSACK, NJ / ACCESSWIRE / 8. Januar 2025 / Champions Oncology, Inc. (NASDAQ: CSBR), eine führende technologiegestützte Organisation im Bereich der onkologischen Forschung, die spezielle Testdienstleistungen...
► Artikel lesen
08.01.Champions Oncology bolsters bioanalytical services2
08.01.Champions Oncology, Inc.: Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership194HACKENSACK, NJ / ACCESSWIRE / January 8, 2025 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading technology-enabled oncology research organization with specialty testing services, is excited to announce...
► Artikel lesen
16.12.24CHAMPIONS ONCOLOGY, INC. - 10-Q, Quarterly Report-
11.12.24Recap: Champions Oncology Q2 Earnings2
11.12.24Champions Oncology Non-GAAP EPS of $0.05 beats by $0.04, revenue of $135.5M beats by $122.45M3
11.12.24Champions Oncology, Inc.: Champions Oncology Reports Quarterly Revenue of $13.5 Million Adjusted EBITDA of $1.1 Million243HACKENSACK, NJ / ACCESSWIRE / December 11, 2024 / Champions Oncology, Inc. (Nasdaq:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, today...
► Artikel lesen
11.12.24CHAMPIONS ONCOLOGY, INC. - 8-K, Current Report-
10.12.24A Peek at Champions Oncology's Future Earnings2
05.12.24Champions Oncology, Inc.: Champions Oncology to Announce Second Quarter Financial Results on Wednesday, December 11, 2024262HACKENSACK, NJ / ACCESSWIRE / December 5, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will...
► Artikel lesen
30.10.24CHAMPIONS ONCOLOGY, INC. - S-8, Securities to be offered to employees in employee benefit plans-
16.10.24Champions Oncology, Inc.: Champions Oncology Announces Agreement with Weill Cornell Medicine176HACKENSACK, NJ / ACCESSWIRE / October 16, 2024 / Champions Oncology, Inc. (Nasdaq:CSBR), a leader in the development of advanced preclinical oncology solutions, is pleased to announce a licensing agreement...
► Artikel lesen
16.10.24Champions Oncology secures Weill Cornell PDX models license1
Seite:  Weiter >>
28 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1